- HOME
- Áø·á°ú/Ŭ¸®´Ð/¼¾ÅÍ
- Àü¹®Å¬¸®´Ð
- ¼Ò¾Æû¼Ò³â ³»ºÐºñ¼ºÀå Ŭ¸®´Ð
- ÀÇ·áÁø
ÀÇ·áÁø ã±â
¾Æ·¡ °Ë»öÀ» ÅëÇØ Á¤È®ÇÏ°í ºü¸£°Ô ÀÇ·áÁøÀ» °Ë»öÇÒ ¼ö ÀÖ½À´Ï´Ù.
Ŭ¸®´Ð ¾È³»
Ŭ¸®´ÐÀ» ¾È³»ÇØ µå¸³´Ï´Ù. Ŭ¸¯ ½Ã ÇØ´ç Ŭ¸®´ÐÀÇ ÀÚ¼¼ÇÑ »çÇ×À» º¸½Ç ¼ö ÀÖ½À´Ï´Ù.
¼Ò¾Æû¼Ò³â ³»ºÐºñ¼ºÀå Ŭ¸®´Ð
-
±× ¿Ü ´Ù¼ö
/
-
[SCI]
Serum levels of thyroid stimulating hormone and luteinizing hormone are decreased in girls with central precocious puberty after 12-months
/ Serum levels of thyroid stimulating hormone and luteinizing hormone are decreased in girls with central precocious puberty after 12-months
/ 202010
-
Prevalence of idiopathic scoliosis in girls with central precocious puberty: effect of a gonadotropin-releasing hormone agonist
/ Prevalence of idiopathic scoliosis in girls with central precocious puberty: effect of a gonadotropin-releasing hormone agonist
/ 202006
-
[SCI]
Role of NPR2 mutation in idiopathic short stature: identification of two novel mutations
/ Role of NPR2 mutation in idiopathic short stature: identification of two novel mutations
/ 202001
-
[SCI]
Ease of use, Preference, and Safety of the Recombinant Human Growth Hormone Disposable Pen Compared with the Reusable Device: A Multicenter, Single-Arm, Open-Label, Switch-Over, Prospective, Phase IV Trial
/ Ease of use, Preference, and Safety of the Recombinant Human Growth Hormone Disposable Pen Compared with the Reusable Device: A Multicenter, Single-Arm, Open-Label, Switch-Over, Prospective, Phase IV Trial
/ 201912